N-Ethylbuphedrone
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by InternetArchiveBot (talk | contribs) at 18:57, 11 April 2020 (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:57, 11 April 2020 by InternetArchiveBot (talk | contribs) (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0)
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.274 g·mol−1 |
3D model (JSmol) | |
| |
|
N-Ethylbuphedrone (also known as NEB) is a stimulant of the cathinone class that has been sold as a designer drug.[1] It is the β-ketone analogue of N,alpha-diethylphenylethylamine.
Legal status
As of October 2015 NEB is a controlled substance in China.[2]
See also
References
- ^ "N-Ethylbuphedrone". Cayman Chemical.
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |